Cabot (NYSE:CBT) Price Target Raised to $103.00 at UBS Group

Cabot (NYSE:CBT) had its price objective boosted by research analysts at UBS Group from $100.00 to $103.00 in a report issued on Tuesday, Benzinga reports. The brokerage currently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group’s price target would indicate a potential upside of 1.90% from the stock’s previous close.

Other equities research analysts have also issued reports about the stock. Mizuho increased their target price on shares of Cabot from $104.00 to $109.00 and gave the stock a “buy” rating in a report on Tuesday. StockNews.com lowered Cabot from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 14th. Finally, Deutsche Bank Aktiengesellschaft cut Cabot from a “buy” rating to a “hold” rating and increased their target price for the stock from $88.00 to $95.00 in a research note on Thursday, April 18th. Three equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $93.67.

Cabot Stock Up 0.0 %

Shares of NYSE:CBT opened at $101.08 on Tuesday. The company has a 50 day moving average of $91.52 and a 200-day moving average of $82.05. The stock has a market cap of $5.60 billion, a price-to-earnings ratio of 13.13, a P/E/G ratio of 1.00 and a beta of 1.27. Cabot has a one year low of $63.73 and a one year high of $103.46. The company has a debt-to-equity ratio of 0.74, a current ratio of 2.04 and a quick ratio of 1.30.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, May 6th. The specialty chemicals company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.66 by $0.12. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.04 billion. Cabot had a return on equity of 25.52% and a net margin of 11.24%. The firm’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.33 earnings per share. On average, sell-side analysts forecast that Cabot will post 6.58 earnings per share for the current year.

Insider Buying and Selling

In other Cabot news, EVP Jeff Ji Zhu sold 55,233 shares of Cabot stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total value of $4,413,669.03. Following the sale, the executive vice president now directly owns 97,201 shares in the company, valued at approximately $7,767,331.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 3.07% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Cabot

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC raised its position in Cabot by 143.1% during the fourth quarter. EverSource Wealth Advisors LLC now owns 333 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 196 shares in the last quarter. Arlington Trust Co LLC acquired a new position in shares of Cabot during the 4th quarter worth about $34,000. Hexagon Capital Partners LLC raised its holdings in shares of Cabot by 81.8% in the 4th quarter. Hexagon Capital Partners LLC now owns 460 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 207 shares during the period. SRS Capital Advisors Inc. grew its holdings in Cabot by 372.0% during the fourth quarter. SRS Capital Advisors Inc. now owns 505 shares of the specialty chemicals company’s stock worth $42,000 after purchasing an additional 398 shares during the period. Finally, GAMMA Investing LLC acquired a new position in Cabot during the fourth quarter worth approximately $44,000. Institutional investors own 93.18% of the company’s stock.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.